drugset / Trial / NCT07169695

A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

NCT07169695 ↗

Phase 2 Recruiting 120 enrolled Laboratoires Thea
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis

Timeline

Start
2026-03-24
Primary completion
2027-01-21
Completion
2027-01-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide — Other
Subject T1695 Unknown — Other